Cell Growth & Differentiation, Vol 7, Issue 11 1513-1523, Copyright © 1996 by American Association of Cancer Research

ARTICLES

Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers

H Sakata, H Takayama, R Sharp, JS Rubin, G Merlino and WJ LaRochelle
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, Maryland 20892, USA.

To investigate the in vivo role of hepatocyte growth factor/scatter factor (HGF/SF) in liver function, we generated transgenic mice using a mouse HGF/SF cDNA under the control of the mouse metallothionein gene promoter and 5'/3' flanking sequences. In adult HGF/SF transgenic mice, liver weight as a percentage of total body weight was at least twice that of wild-type mice. Comparison of transgenic and control liver morphology revealed dramatic heterogeneity in the size and appearance of hepatocytes as a distinctive feature of HGF/SF overexpression. Transgenic livers exhibited a significant increase in the number of small hepatocytes with a 2N DNA content, accounting for the observed increase in liver mass. The DNA labeling index of hepatocytes increased 11-fold at 4 weeks of age, when liver enlargement first became apparent, and was still elevated about 5-fold in adult HGF/SF transgenic mice. Moreover, hepatocytes isolated by perfusion of transgenic livers doubled every 2 days in culture, whereas little or no growth was observed with isolated control hepatocytes. The mechanistic basis of hepatocyte proliferation was elucidated as the chronic activation of the c-met proto-oncogene product. Met and substrates such as phosphatidylinositol 3-kinase, Src homology and collagen-like, pp60c-src, focal adhesion kinase p125FAK, and paxillin were associated with tyrosine-phosphorylated complexes in a hepatocyte cell line established from the transgenic liver. This proliferative stimulus triggered the formation of hepatocellular adenomas and/or carcinomas in most transgenic mice > or = 1.5 years of age. Finally, the rate of transgenic mouse liver regeneration was increased 3-fold over control livers following partial hepatectomy.

This article has been cited by other articles:

				T. Takami, P. Kaposi-Novak, K. Uchida, L. E. Gomez-Quiroz, E. A. Conner, V. M. Factor, and S. S. Thorgeirsson Loss of Hepatocyte Growth Factor/c-Met Signaling Pathway Accelerates Early Stages of N-nitrosodiethylamine Induced Hepatocarcinogenesis Cancer Res., October 15, 2007; 67(20): 9844 - 9851. [Abstract] [Full Text] [PDF]

				T. Kosone, H. Takagi, N. Horiguchi, Y. Ariyama, T. Otsuka, N. Sohara, S. Kakizaki, K. Sato, and M. Mori HGF ameliorates a high-fat diet-induced fatty liver Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G204 - G210. [Abstract] [Full Text] [PDF]

				X. Huang, C. Yu, C. Jin, M. Kobayashi, C. A. Bowles, F. Wang, and W. L. McKeehan Ectopic Activity of Fibroblast Growth Factor Receptor 1 in Hepatocytes Accelerates Hepatocarcinogenesis by Driving Proliferation and Vascular Endothelial Growth Factor-Induced Angiogenesis Cancer Res., February 1, 2006; 66(3): 1481 - 1490. [Abstract] [Full Text] [PDF]

				T. Burgess, A. Coxon, S. Meyer, J. Sun, K. Rex, T. Tsuruda, Q. Chen, S.-Y. Ho, L. Li, S. Kaufman, et al. Fully Human Monoclonal Antibodies to Hepatocyte Growth Factor with Therapeutic Potential against Hepatocyte Growth Factor/c-Met-Dependent Human Tumors Cancer Res., February 1, 2006; 66(3): 1721 - 1729. [Abstract] [Full Text] [PDF]

				J.-S. Lee, J. W. Grisham, and S. S. Thorgeirsson Comparative functional genomics for identifying models of human cancer Carcinogenesis, June 1, 2005; 26(6): 1013 - 1020. [Abstract] [Full Text] [PDF]

				D. Tulasne, J. Deheuninck, F. C. Lourenco, F. Lamballe, Z. Ji, C. Leroy, E. Puchois, A. Moumen, F. Maina, P. Mehlen, et al. Proapoptotic Function of the MET Tyrosine Kinase Receptor through Caspase Cleavage Mol. Cell. Biol., December 1, 2004; 24(23): 10328 - 10339. [Abstract] [Full Text] [PDF]

				C. Dai, J. Yang, S. Bastacky, J. Xia, Y. Li, and Y. Liu Intravenous Administration of Hepatocyte Growth Factor Gene Ameliorates Diabetic Nephropathy in Mice J. Am. Soc. Nephrol., October 1, 2004; 15(10): 2637 - 2647. [Abstract] [Full Text] [PDF]

				D. F. Balkovetz, E. R. Gerrard Jr., S. Li, D. Johnson, J. Lee, J. W. Tobias, K. K. Rogers, R. W. Snyder, and J. H. Lipschutz Gene expression alterations during HGF-induced dedifferentiation of a renal tubular epithelial cell line (MDCK) using a novel canine DNA microarray Am J Physiol Renal Physiol, April 1, 2004; 286(4): F702 - F710. [Abstract] [Full Text] [PDF]

				K. Fukai, O. Yokosuka, T. Chiba, Y. Hirasawa, M. Tada, F. Imazeki, H. Kataoka, and H. Saisho Hepatocyte Growth Factor Activator Inhibitor 2/Placental Bikunin (HAI-2/PB) Gene Is Frequently Hypermethylated in Human Hepatocellular Carcinoma Cancer Res., December 15, 2003; 63(24): 8674 - 8679. [Abstract] [Full Text] [PDF]

				V. Wallenius, K. Wallenius, M. Hisaoka, J. Sandstedt, C. Ohlsson, M. Kopf, and J.-O. Jansson Retarded Liver Growth in Interleukin-6-Deficient and Tumor Necrosis Factor Receptor-1-Deficient Mice Endocrinology, July 1, 2001; 142(7): 2953 - 2960. [Abstract] [Full Text] [PDF]

				M. Sachs, H. Brohmann, D. Zechner, T. Muller, J. Hulsken, I. Walther, U. Schaeper, C. Birchmeier, and W. Birchmeier Essential Role of Gab1 for Signaling by the c-Met Receptor In Vivo J. Cell Biol., September 18, 2000; 150(6): 1375 - 1384. [Abstract] [Full Text] [PDF]

				F. NÚÑEZ, M. D. CHIPCHASE, A. R. CLARKE, and D. W. MELTON Nucleotide excision repair gene (ERCC1) deficiency causes G2 arrest in hepatocytes and a reduction in liver binucleation: the role of p53 and p21 FASEB J, June 1, 2000; 14(9): 1073 - 1082. [Abstract] [Full Text]

				T. Otsuka, J. Jakubczak, W. Vieira, D. P. Bottaro, D. Breckenridge, W. J. Larochelle, and G. Merlino Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates Metastasis Mol. Cell. Biol., March 15, 2000; 20(6): 2055 - 2065. [Abstract] [Full Text]

				J. L. Jakubczak, W. J. Larochelle, and G. Merlino NK1, a Natural Splice Variant of Hepatocyte Growth Factor/Scatter Factor, Is a Partial Agonist In Vivo Mol. Cell. Biol., March 1, 1998; 18(3): 1275 - 1283. [Abstract] [Full Text]

				H. Takayama, W. J. LaRochelle, R. Sharp, T. Otsuka, P. Kriebel, M. Anver, S. A. Aaronson, and G. Merlino Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor PNAS, January 21, 1997; 94(2): 701 - 706. [Abstract] [Full Text] [PDF]

				T. C. Weglarz and E. P. Sandgren Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous PNAS, November 7, 2000; 97(23): 12595 - 12600. [Abstract] [Full Text] [PDF]